Intravenous abciximab for parent vessel thrombus during basilar apex aneurysm coil embolization

Case report and literature review

Bernard Bendok, David J. Padalino, Elad I. Levy, Adnan I. Qureshi, Lee R. Guterman, L. Nelson Hopkins

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Background Parent vessel thrombus formation is a serious complication of intracranial aneurysm embolization. The management of this issue is controversial. Abciximab, a potent platelet inhibitor, has been shown to have thrombolytic effects during coronary interventions. A small number of cases have demonstrated its potential application in neuroendovascular procedures. We review the literature on the management of parent vessel thrombosis during aneurysm coil embolization and report our successful experience with the use of IV abciximab to treat parent vessel thrombus formation related to coil embolization of a basilar apex aneurysm. Case description A 45-year-old man presented to our center with an incidental basilar apex aneurysm. After being informed of the surgical and endovascular treatment options, he elected to undergo coil embolization of the aneurysm. During the procedure, acute thrombus was noted in the left P1 segment of the posterior cerebral artery. IV abciximab was administered, and an angiogram the following day showed complete dissolution of the clot. The patient had no neurologic sequelae. Conclusions IV abciximab appears to be an effective option in the management of acute parent vessel thrombus encountered during coil embolization of unruptured aneurysms. Sufficient data are lacking regarding its use in the setting of a ruptured aneurysm.

Original languageEnglish (US)
Pages (from-to)304-311
Number of pages8
JournalSurgical Neurology
Volume62
Issue number4
DOIs
StatePublished - Oct 2004
Externally publishedYes

Fingerprint

Aneurysm
Thrombosis
Posterior Cerebral Artery
Ruptured Aneurysm
Platelet Aggregation Inhibitors
Intracranial Aneurysm
Nervous System
Angiography
abciximab
Therapeutics

Keywords

  • Abciximab
  • aneurysm
  • coils
  • thrombus

ASJC Scopus subject areas

  • Clinical Neurology
  • Surgery

Cite this

Intravenous abciximab for parent vessel thrombus during basilar apex aneurysm coil embolization : Case report and literature review. / Bendok, Bernard; Padalino, David J.; Levy, Elad I.; Qureshi, Adnan I.; Guterman, Lee R.; Hopkins, L. Nelson.

In: Surgical Neurology, Vol. 62, No. 4, 10.2004, p. 304-311.

Research output: Contribution to journalArticle

Bendok, Bernard ; Padalino, David J. ; Levy, Elad I. ; Qureshi, Adnan I. ; Guterman, Lee R. ; Hopkins, L. Nelson. / Intravenous abciximab for parent vessel thrombus during basilar apex aneurysm coil embolization : Case report and literature review. In: Surgical Neurology. 2004 ; Vol. 62, No. 4. pp. 304-311.
@article{9a89f2d2807d4659b3c64b4f431e6fca,
title = "Intravenous abciximab for parent vessel thrombus during basilar apex aneurysm coil embolization: Case report and literature review",
abstract = "Background Parent vessel thrombus formation is a serious complication of intracranial aneurysm embolization. The management of this issue is controversial. Abciximab, a potent platelet inhibitor, has been shown to have thrombolytic effects during coronary interventions. A small number of cases have demonstrated its potential application in neuroendovascular procedures. We review the literature on the management of parent vessel thrombosis during aneurysm coil embolization and report our successful experience with the use of IV abciximab to treat parent vessel thrombus formation related to coil embolization of a basilar apex aneurysm. Case description A 45-year-old man presented to our center with an incidental basilar apex aneurysm. After being informed of the surgical and endovascular treatment options, he elected to undergo coil embolization of the aneurysm. During the procedure, acute thrombus was noted in the left P1 segment of the posterior cerebral artery. IV abciximab was administered, and an angiogram the following day showed complete dissolution of the clot. The patient had no neurologic sequelae. Conclusions IV abciximab appears to be an effective option in the management of acute parent vessel thrombus encountered during coil embolization of unruptured aneurysms. Sufficient data are lacking regarding its use in the setting of a ruptured aneurysm.",
keywords = "Abciximab, aneurysm, coils, thrombus",
author = "Bernard Bendok and Padalino, {David J.} and Levy, {Elad I.} and Qureshi, {Adnan I.} and Guterman, {Lee R.} and Hopkins, {L. Nelson}",
year = "2004",
month = "10",
doi = "10.1016/j.surneu.2003.10.045",
language = "English (US)",
volume = "62",
pages = "304--311",
journal = "World Neurosurgery",
issn = "1878-8750",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Intravenous abciximab for parent vessel thrombus during basilar apex aneurysm coil embolization

T2 - Case report and literature review

AU - Bendok, Bernard

AU - Padalino, David J.

AU - Levy, Elad I.

AU - Qureshi, Adnan I.

AU - Guterman, Lee R.

AU - Hopkins, L. Nelson

PY - 2004/10

Y1 - 2004/10

N2 - Background Parent vessel thrombus formation is a serious complication of intracranial aneurysm embolization. The management of this issue is controversial. Abciximab, a potent platelet inhibitor, has been shown to have thrombolytic effects during coronary interventions. A small number of cases have demonstrated its potential application in neuroendovascular procedures. We review the literature on the management of parent vessel thrombosis during aneurysm coil embolization and report our successful experience with the use of IV abciximab to treat parent vessel thrombus formation related to coil embolization of a basilar apex aneurysm. Case description A 45-year-old man presented to our center with an incidental basilar apex aneurysm. After being informed of the surgical and endovascular treatment options, he elected to undergo coil embolization of the aneurysm. During the procedure, acute thrombus was noted in the left P1 segment of the posterior cerebral artery. IV abciximab was administered, and an angiogram the following day showed complete dissolution of the clot. The patient had no neurologic sequelae. Conclusions IV abciximab appears to be an effective option in the management of acute parent vessel thrombus encountered during coil embolization of unruptured aneurysms. Sufficient data are lacking regarding its use in the setting of a ruptured aneurysm.

AB - Background Parent vessel thrombus formation is a serious complication of intracranial aneurysm embolization. The management of this issue is controversial. Abciximab, a potent platelet inhibitor, has been shown to have thrombolytic effects during coronary interventions. A small number of cases have demonstrated its potential application in neuroendovascular procedures. We review the literature on the management of parent vessel thrombosis during aneurysm coil embolization and report our successful experience with the use of IV abciximab to treat parent vessel thrombus formation related to coil embolization of a basilar apex aneurysm. Case description A 45-year-old man presented to our center with an incidental basilar apex aneurysm. After being informed of the surgical and endovascular treatment options, he elected to undergo coil embolization of the aneurysm. During the procedure, acute thrombus was noted in the left P1 segment of the posterior cerebral artery. IV abciximab was administered, and an angiogram the following day showed complete dissolution of the clot. The patient had no neurologic sequelae. Conclusions IV abciximab appears to be an effective option in the management of acute parent vessel thrombus encountered during coil embolization of unruptured aneurysms. Sufficient data are lacking regarding its use in the setting of a ruptured aneurysm.

KW - Abciximab

KW - aneurysm

KW - coils

KW - thrombus

UR - http://www.scopus.com/inward/record.url?scp=4644329405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644329405&partnerID=8YFLogxK

U2 - 10.1016/j.surneu.2003.10.045

DO - 10.1016/j.surneu.2003.10.045

M3 - Article

VL - 62

SP - 304

EP - 311

JO - World Neurosurgery

JF - World Neurosurgery

SN - 1878-8750

IS - 4

ER -